Saturday, 2 August 2014

Mutation of IgM antibodies in MS

MS is a B-cell mediated disease. Can we find the cause? #MSBlog #MSResearch

"More on B cells. For those of you who are not immunologists the following paper will be seem confusing. B cells are the types of lymphocyte that mature to make antibodies. When they are naive, i.e. have not participated in a specific immune reaction, the carry on them a primitive, or early, IgM antibody; we refer to these primitive antibodies as been germline antibodies as they are hardwired in our genomes. When the B cells are involved in an immune response they change the type of antibody on their surface by mutating it to recognise a specific antigen or protein (somatic hypermutation) or changing it from an IgM to IgG (isotype switching). The new DNA sequences generated by this process are not in our genomes, but only exist in the B-cells of that specific clone. Both somatic hypermutation and isotype switching leave behind molecular fingerprints that can be detected using modern DNA technology and compared to the germline sequences. I hope this is not to confusing?"

"What the paper below is showing is that B-cells expressing IgM in  the spinal fluid of MSers are not naive B-cells (germline IgM) but express IgM antibody molecules on  their surface that have undergone hypermutation (antigen selected); in other words these antibodies have been selected to react with a specific antigen. This indicates that something is driving the maturation of IgM expressing B cells within the central nervous system of MSers, similar to what happens with IgG. What is the antigen or antigens responsible for this? This is the million dollar question. If we could only find the antigen(s) driving these B cells response we will be much closer to knowing the cause of MS. Why do I say this? In infectious diseases in which we know the infecting organism we find that the vast majority of the IgM and IgG molecules that have undergone hypermutation react with antigens from the infecting organism."

"This paper supports the hypothesis that B-cells play a central role in the pathogenesis of MS and B cells hold the clue to the cause of the disease. We already know that all highly-effective DMTs have some activity against B-cell biology within the central nervous system, which also supports the B-cell hypothesis of MS."


Epub: Beltr├ín et al. Intrathecal somatic hypermutation of IgM in multiple sclerosis and neuroinflammation. Brain. 2014 Jul 23. pii: awu205.

Background: Intrathecal oligoclonal bands of the cerebrospinal fluid are considered the most important immunological biomarkers of MS. They typically consist of clonally expanded IgG antibodies that underwent affinity maturation during sustained stimulation by largely unknown antigens. In addition, ∼40% of MSers have oligoclonal bands that consist of expanded IgM antibodies. 

Objectives & Methods: We investigated the molecular composition of IgM- and IgG-chains from cerebrospinal fluid of 12 MSers, seven patients with other neurological diseases, and eight healthy control subjects by high-throughput deep-sequencing and single-cell PCR. Further, we studied the expression of activation-induced cytidine deaminase, the key enzyme for affinity maturation of antibodies, in cerebrospinal fluid samples of 16 patients. 

Results: From the cerebrospinal fluid of two MSers we isolated single B cells and investigated the co-expression of antibody chains with activation-induced cytidine deaminase. In striking contrast to IgM-chains from peripheral blood, IgM-chains from cerebrospinal fluid of MSers or neuroborreliosis showed a high degree of somatic hypermutation. We found a high content of mutations that caused amino acid exchanges as compared to silent mutations. In addition, more mutations were found in the complementarity determining regions of the IgM-chains, which interact with yet unknown antigens, as compared to framework regions. Both observations provide evidence for antigen-driven affinity maturation. Furthermore, single B cells from the cerebrospinal fluid of MSers co-expressed somatically hypermutated IgM-chains and activation-induced cytidine deaminase, an enzyme that is crucial for somatic hypermutation and class switch recombination of antibodies and is normally expressed during activation of B cells in germinal centres. Clonal tracking of particular IgM+ B cells allowed us to relate unmutated ancestor clones in blood to hypermutated offspring clones in CSF. Unexpectedly, however, we found no evidence for intrathecal isotype switching from IgM to IgG. 

Conclusions: Our data suggest that the intrathecal milieu sustains a germinal centre-like reaction with clonal expansion and extensive accumulation of somatic hypermutation in IgM-producing B cells.

9 comments:

  1. So B-cell are reacting to something...
    Are B-cell wrongly reacting (Auto Immune reaction) or are B-cell reacting to an infection? (EBV for instance)
    Are Researchers trying to find an answer?

    ReplyDelete
  2. Re I hope this is not to confusing?
    No, your explanation till that point is quite clear. Becomes more confusing after that

    Question: The background it says "In addition, ∼40% of MSers have oligoclonal bands that consist of expanded IgM antibodies"
    What does that imply? How are these 40% different?

    ReplyDelete
    Replies
    1. http://multiple-sclerosis-research.blogspot.co.uk/2014/07/no-oligoclonal-bands-in-your-csf-means.html

      Delete
    2. I think it says that 40% have different oligoclonal bands from the remaining 60%

      Typical oligoclonal bands consist of "clonally expanded IgG antibodies" and in 40% they consist of "expanded IgM antibodies"

      Delete
  3. Are researchers too focused on trying to find a single cause when speaking to other MSers it seems obvious to me we fall into different groups. Those of us who have a genetic predisposition to MS can have any number of triggers to set it off. I would like to see more detailed blood-work done to identify viruses and bacterial infection. Try to work with the immune system to clear up what we can rather than suppress it, so that the body is working with one hand tide behind its back.

    ReplyDelete
  4. How do you consider the benefits of mitoxantrone in addressing this issue? Is mitox a good therapy for progressive MS?

    ReplyDelete
    Replies
    1. http://multiple-sclerosis-research.blogspot.co.uk/2014/07/leukaemia-risk-from-mitoxantrone-higher.html

      Delete
  5. "MS is a B-cell mediated disease in Giovannoni's opinion".

    Fixed it for you.

    http://www.sciencedirect.com/science/article/pii/S0925443910001572

    ReplyDelete

Please note that all comments are moderated and any personal or marketing-related submissions will not be shown.